目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing the Study
Intended Audience
What's New in This Update?
Scope of Report
Methodology
Information Sources
Geographical Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table Summary : Global Molecular Diagnostic Market, by Region, Through 2026
Figure 0A : Global Molecular Diagnostic Market, by Region, 2019-2026
Figure 0B : Global Molecular Diagnostic Market Shares, by Region, 2020

Chapter- 3: Overview
Introduction to Genomic Diagnostics
Expression Profiling and Disease
Expression Profiling and Infectious Disease
DNA Sequencing for Genotyping and Diagnosis
Clinical Pharmacology
Mutation Detection and Genotyping for Specific Genes
Identification of New Disease Genes

Chapter- 4: Impact of the COVID-19 Pandemic
Introduction
Impact of COVID-19 on Market
Changes in Consumption Trends for Health-Related Products

Chapter- 5: Market Dynamics
Market Drivers
Restraints and Challenges
Opportunities

Chapter- 6: Market Breakdown by Technology
Microarrays
PCR
In Situ Hybridization
Others
Table 4 : Global Molecular Diagnostic Market, by Technology, Through 2026
Figure 9 : Global Molecular Diagnostic Market Shares, by Technology, 2020
Figure 10 : Global Molecular Diagnostic Market, by Technology, 2019-2026

Chapter- 7: Molecular Diagnostics by Application
Infectious Diseases
Oncology
Pre- and Post-Natal Screening
Identity and Paternity
Others
Table 5 : Global Molecular Diagnostic Market, by Application, Through 2026
Figure 15 : Global Molecular Diagnostic Market Shares, by Application, 2020
Figure 16 : Global Molecular Diagnostic Market, by Application, 2019-2026

Chapter- 8: Market Breakdown by Region
Global Molecular Diagnostic Market by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter- 9: Regulations and Finance
Overview
Insurance
Food and Drug Administration Guidelines
Internal Standards for DNA Diagnostics
Minimum Information about a Microarray
FDA Guidelines for In Vitro Companion Diagnostics

Chapter- 10: Patents
Table 27 : Selected Molecular Diagnostics, 2020-2021

Chapter- 11: Competitive Landscape
Overview

Chapter- 12: Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
ALMAC GROUP
BECTON, DICKINSON AND CO.
BIOMERIEUX SA
BIO-RAD LABORATORIES INC.
CARDINAL HEALTH
DANAHER CORP.
ELITECH GROUP
GENERAL ELECTRIC
HOLOGIC INC.
ILLUMINA INC.
MYRIAD GENETICS
GRIFOLS (NOVARTIS MOLECULAR DIAGNOSTICS)
PHILIPS HEALTHCARE
QIAGEN N.V.
QUEST DIAGNOSTICS
ROCHE HOLDING AG (F. HOFFMANN-LA ROCHE LTD.)
SIEMENS HEALTHCARE
THERMO FISHER SCIENTIFIC INC.